the aid library

LIST OPTIONS

National Strategy and Action Plan for Clubfoot Care in Bangladesh

Dr. A. M. Z. Hussain; Dr. Rizvi; Dr. Qavi; et al. Government of the People's Republic of Bangladesh DGHS Directorate General of Health Services Ministry of Health and Family Welfare ; Sustainable Clubfoot Care in Bangladesh (2015) C2

December 2015 National guidelines for of Clubfoot

Download (147)

View PDF (185)

COVID-19 pandemic in the health of women, children, and adolescents in Latin America and the Caribbean

Castro, A. UNDP (2020) CC

External Link

Cardiovascular diseases in Africa in the twenty-first century: Gaps and priorities going forward

Minja, N.W.; Nakagaayi, D.; Aliku, T. et al. Frontiers in Cardiovascular Medicine (2022) CC

In 2015, the United Nations set important targets to reduce premature cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately bears the brunt of CVD burden and has one of the highest risks of dying from non-communicable diseases (NCDs) worldwide. There is currently an epide...miological transition on the continent, where NCDs is projected to outpace communicable diseases within the current decade. Unchecked increases in CVD risk factors have contributed to the growing burden of three major CVDs—hypertension, cardiomyopathies, and atherosclerotic diseasesleading to devastating rates of stroke and heart failure. The highest age standardized disability-adjusted life years (DALYs) due to hypertensive heart disease (HHD) were recorded in Africa. The contributory causes of heart failure are changing—whilst HHD and cardiomyopathies still dominate, ischemic heart disease is rapidly becoming a significant contributor, whilst rheumatic heart disease (RHD) has shown a gradual decline. In a continent where health systems are traditionally geared toward addressing communicable diseases, several gaps exist to adequately meet the growing demand imposed by CVDs. Among these, high-quality research to inform interventions, underfunded health systems with high out-of-pocket costs, limited accessibility and affordability of essential medicines, CVD preventive services, and skill shortages. Overall, the African continent progress toward a third reduction in premature mortality come 2030 is lagging behind. More can be done in the arena of effective policy implementation for risk factor reduction and CVD prevention, increasing health financing and focusing on strengthening primary health care services for prevention and treatment of CVDs, whilst ensuring availability and affordability of quality medicines. Further, investing in systematic country data collection and research outputs will improve the accuracy of the burden of disease data and inform policy adoption on interventions. This review summarizes the current CVD burden, important gaps in cardiovascular medicine in Africa, and further highlights priority areas where efforts could be intensified in the next decade with potential to improve the current rate of progress toward achieving a 33% reduction in CVD mortality. more

Download (1629)

View PDF (1631)

5th Essential Drugs List and Standard Treatment Guidelines for Zimbabwe

Ministry of Health and Child Welfare, Zimbabwe (2006) C1

National sexual and reproductive health and rights (SRHR) policy

Government of Malawi, Ministry of Health (2009) C1

Download (2098)

View PDF (2133)

Essential Medicines and Health Supplies List for Uganda (EMHSLU) 2016

Ministry of Health Uganda (2016) C1

Download (222)

View PDF (369)

Zambia Consolidated Guidelines for Treatment & Prevention of HIV Infection

Ministry of Health, Zambia (2018) C1

Download (187)

View PDF (210)

Antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in the EU/EEA – addressing the vulnerable populations

C. Savolainen-Kopra; M. Kontio; J. Lindeman; et al. European Centre for Disease Prevention and Control (2017) C2

Scientific Advice

Guidelines for the Prevention and Containment of Antimicrobial Resistance in South African Hospitals

National Department of Health South Africa (2019) C2

These guidelines form part of efforts to institutionalise the prevention and containment of antimicrobial resistance (AMR) in health care facilities in South Africa, as outlined in the Antimicrobial Resistance Strategic Framework and Implementation Plan. The focus of these guidelines is on two inte... more

Download (128)

View PDF (189)

Situation Analysis and Recommendations: Antibiotic Use and Resistance in Kenya

Kenya Medical Research Institute (2011) C2

In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid, ... more

Download (172)

View PDF (198)

Guidelines for the Prevention and Contaiment of of Antimicrobial Resistance in South African Hospitals
recommended

NdOH South Africa National Department of Health South Africa (2018) C1

These guidelines form part of efforts to institutionalize the prevention and containment of antimicrobial resistance (AMR) in healthcare facilities in South Africa, as outlined in the Antimicrobial Resistance Strategic Framework and Implementation Plan. The focus of these guidelines is on two interr... more

Praziquantel for the treatment of schistosomiasis during human pregnancy

Friedman, J.F. et al. (2018) CC

In 2014, an estimated 40 million women of reproductive age were infected with Schistosoma haematobium, S. japonicum and/or S. mansoni. In both 2003 and 2006, the World Health Organization (WHO) recommended that all schistosome-infected pregnant and breastfeeding women be offered treatment, with praz... more

Grandes Realistions MSPP 2014-2015 Tome 1

Ministère de la Santé Publique et de la Population, Haiti (2015) C_WHO

Download (1412)

View PDF (1756)

India Newborn Action Plan (INAP)

Ministry of Health and Social Welfare, Government of India (2014) C1

Download (465)

View PDF (596)

Guidelines for the diagnosis and treatment of Chagas disease
recommended

World Health Organization WHO (2019) C_WHO

This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were prepared following the WHO handbook for guideline dev... more